ScreenerHero

ICO Iconovo AB (publ)

STO · SE · Healthcare · Medical Devices · iconovo.se
1.265SEK+1.20%Mkt Cap: 11.64M $P/E: —

Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$174.36BUSDP/E 32.3
MDT
Medtronic plc
$112.53BUSDP/E 21.6
SYK
Stryker Corporation
$109.40BUSDP/E 29.6
BSX
Boston Scientific Corporation
$61.45BUSDP/E 17.2
EW
Edwards Lifesciences Corporation
$50.23BUSDP/E 51.9
SHL
Siemens Healthineers AG
$46.06BUSDP/E 19.2
DXCM
DexCom, Inc. - Common Stock
$32.21BUSDP/E 33.7
GEHC
GE HealthCare Technologies Inc. - Common Stock
$29.24BUSDP/E 14.8
PHG
Koninklijke Philips N.V.
$23.37BUSDP/E 17.8
PHIA
Koninklijke Philips N.V.
$22.58BUSDP/E 18.5
STE
STERIS plc
$20.58BUSDP/E 25.8
SOON
Sonova Holding AG
$17.06BUSDP/E 27.9
ZBH
Zimmer Biomet Holdings, Inc.
$17.47BUSDP/E 22.2
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
TXG
10x Genomics, Inc. - Common Stock
$12.18BUSD
SNN
Smith & Nephew plc
$11.27BUSDP/E 18.3
GMED
Globus Medical, Inc.
$10.28BUSDP/E 19.6
BIO
Bio-Rad Laboratories, Inc.
$10.16BUSDP/E 48.1
DEMANT
Demant A/S
$9.81BUSDP/E 27.8
GKOS
Glaukos Corporation
$9.67BUSD

Key Statistics

Company
Market Cap11.64M USD
Enterprise Value8.36M USD
Revenue (TTM)164.68K USD
Gross Profit1.10M USD
Net Income (TTM)-4.15M USD
Revenue/Share0.03 SEK
Last Price1.265 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees12
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.14
PEG—
EV/EBITDA-2.31
EV/Revenue50.77
P/S69.82
P/B0.81
EPS (TTM)-0.61
EPS (Forward)-1.10
52W Range
0.870024% of range2.500
52W High2.500 SEK
52W Low0.8700 SEK
Profitability
Gross Margin1042.65%
Oper. Margin-1737.87%
EBITDA Margin0.00%
Profit Margin-3925.50%
ROE-36.77%
ROA-33.08%
Growth
Revenue Growth322.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.05M USD
CapEx (TTM)1.35M USD
FCF Margin-1771.41%
FCF Yield-25.07%
Net Debt-3.14M USD
Net Debt/EBITDA0.86
Balance Sheet
Debt/Equity0.03
Current Ratio3.06
Quick Ratio3.06
Book Value/Sh1.55 SEK
Cash/Share0.39 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.8000 SEK
Upside (mean)-36.8%
Target Range0.8000 SEK – 0.8000 SEK
# Analysts1
Ownership
Shares Out.96.17M
Float92.64M
Insiders46.97%
Institutions36.39%
Technical
SMA 501.177 (+7.5%)
SMA 2001.152 (+9.8%)
Beta0.42
S&P 52W Chg14.58%
Avg Vol (30d)58.47K
Avg Vol (10d)42.89K
Technical Indicators
RSI (14)52.5
MACD0.0098
MACD Signal0.0151
MACD Hist.-0.0053
BB Upper1.388 SEK
BB Middle1.258 SEK
BB Lower1.129 SEK
BB Width20.60%
ATR (14)0.0698 SEK
Vol Ratio (20d)0.48x